Professor of Medicine at Harvard Medical School and Director of Liver Cancer Research at Massachusetts General Hospital Cancer Center.
He is an internationally recognized expert in hepatocellular carcinoma and cholangiocarcinoma.
Director of the Internal Medicine Department in Mainz, Germany.
He is an expert in apoptotic cell death in the liver, immune escape of tumor cells, and the clinical and molecular aspects of HCC.
Professor of Clinical Medicine at the Geffen School of Medicine, UCLA, USA, and Director of the Signal Transduction and Therapeutics Program at the Jonsson Comprehensive Cancer Center, UCLA, USA.
He is an expert in translating molecular understanding into novel target therapies for hepatobiliary cancers.